表紙：呼吸器感染症治療薬の世界市場 (2022～2030年)：成長・将来の展望・競合分析

市場調査レポート

商品コード

1182411

呼吸器感染症治療薬の世界市場 (2022～2030年)：成長・将来の展望・競合分析

Respiratory Tract Infection Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030

出版日: 2022年08月11日 | 発行: Acute Market Reports

| ページ情報: 英文 120 Pages | 納期: 即日から翌営業日

価格

PDF (Single User License)

USD 4,500 707,130円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 6,500 1,021,410円

レポートPDFを10名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 9,000 1,414,260円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

呼吸器疾患の有病率の上昇、絶えず変化する気候、大気汚染の上昇、個人衛生の維持への注力の拡大などの要因が呼吸器感染症治療薬市場の成長を促進しています。

地域別では、北米が2021年に最大の規模を示しました。この成長は主に、呼吸器系の合併症を患っている人口が多いこと、個人の衛生状態を維持する傾向があること、有利な償還シナリオなどの要因に起因しています。一方、涼しく湿った気候、呼吸器感染症治療薬の規制当局による承認などかｒ、欧州地域が第2位の市場になると予想されています。

当レポートでは、世界の呼吸器感染症治療薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、主要企業のプロファイルなどをまとめています。

List of Tables

TABLE 1 Global Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 2 Global Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 3 Global Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 4 Global Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 5 Global Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 6 Global Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 7 Global Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 8 Global Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 9 Global Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 10 Global Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 11 North America Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 12 North America Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 13 North America Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 14 North America Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 15 North America Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 16 North America Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 17 North America Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 18 North America Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 19 North America Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 20 North America Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 21 U.S. Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 22 U.S. Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 23 U.S. Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 24 U.S. Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 25 U.S. Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 26 U.S. Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 27 U.S. Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 28 U.S. Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 29 U.S. Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 30 U.S. Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 31 Canada Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 32 Canada Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 33 Canada Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 34 Canada Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 35 Canada Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 36 Canada Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 37 Canada Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 38 Canada Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 39 Canada Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 40 Canada Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 41 Rest of North America Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 42 Rest of North America Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 43 Rest of North America Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 44 Rest of North America Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 45 Rest of North America Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 46 Rest of North America Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 47 Rest of North America Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 48 Rest of North America Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 49 Rest of North America Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 50 Rest of North America Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 51 UK and European Union Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 52 UK and European Union Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 53 UK and European Union Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 54 UK and European Union Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 55 UK and European Union Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 56 UK and European Union Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 57 UK and European Union Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 58 UK and European Union Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 59 UK and European Union Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 60 UK and European Union Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 61 UK Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 62 UK Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 63 UK Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 64 UK Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 65 UK Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 66 UK Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 67 UK Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 68 UK Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 69 UK Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 70 UK Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 71 Germany Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 72 Germany Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 73 Germany Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 74 Germany Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 75 Germany Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 76 Germany Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 77 Germany Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 78 Germany Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 79 Germany Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 80 Germany Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 81 Spain Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 82 Spain Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 83 Spain Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 84 Spain Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 85 Spain Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 86 Spain Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 87 Spain Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 88 Spain Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 89 Spain Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 90 Spain Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 91 Italy Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 92 Italy Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 93 Italy Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 94 Italy Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 95 Italy Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 96 Italy Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 97 Italy Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 98 Italy Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 99 Italy Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 100 Italy Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 101 France Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 102 France Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 103 France Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 104 France Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 105 France Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 106 France Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 107 France Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 108 France Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 109 France Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 110 France Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 111 Rest of Europe Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 112 Rest of Europe Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 113 Rest of Europe Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 114 Rest of Europe Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 115 Rest of Europe Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 116 Rest of Europe Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 117 Rest of Europe Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 118 Rest of Europe Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 119 Rest of Europe Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 120 Rest of Europe Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 121 Asia Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 122 Asia Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 123 Asia Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 124 Asia Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 125 Asia Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 126 Asia Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 127 Asia Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 128 Asia Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 129 Asia Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 130 Asia Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 131 China Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 132 China Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 133 China Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 134 China Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 135 China Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 136 China Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 137 China Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 138 China Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 139 China Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 140 China Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 141 Japan Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 142 Japan Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 143 Japan Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 144 Japan Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 145 Japan Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 146 Japan Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 147 Japan Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 148 Japan Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 149 Japan Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 150 Japan Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 151 India Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 152 India Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 153 India Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 154 India Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 155 India Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 156 India Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 157 India Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 158 India Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 159 India Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 160 India Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 161 Australia Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 162 Australia Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 163 Australia Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 164 Australia Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 165 Australia Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 166 Australia Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 167 Australia Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 168 Australia Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 169 Australia Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 170 Australia Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 171 South Korea Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 172 South Korea Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 173 South Korea Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 174 South Korea Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 175 South Korea Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 176 South Korea Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 177 South Korea Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 178 South Korea Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 179 South Korea Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 180 South Korea Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 181 Latin America Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 182 Latin America Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 183 Latin America Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 184 Latin America Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 185 Latin America Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 186 Latin America Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 187 Latin America Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 188 Latin America Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 189 Latin America Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 190 Latin America Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 191 Brazil Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 192 Brazil Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 193 Brazil Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 194 Brazil Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 195 Brazil Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 196 Brazil Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 197 Brazil Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 198 Brazil Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 199 Brazil Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 200 Brazil Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 201 Mexico Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 202 Mexico Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 203 Mexico Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 204 Mexico Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 205 Mexico Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 206 Mexico Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 207 Mexico Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 208 Mexico Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 209 Mexico Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 210 Mexico Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 211 Rest of Latin America Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 212 Rest of Latin America Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 213 Rest of Latin America Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 214 Rest of Latin America Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 215 Rest of Latin America Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 216 Rest of Latin America Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 217 Rest of Latin America Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 218 Rest of Latin America Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 219 Rest of Latin America Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 220 Rest of Latin America Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 221 Middle East and Africa Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 222 Middle East and Africa Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 223 Middle East and Africa Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 224 Middle East and Africa Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 225 Middle East and Africa Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 226 Middle East and Africa Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 227 Middle East and Africa Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 228 Middle East and Africa Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 229 Middle East and Africa Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 230 Middle East and Africa Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 231 GCC Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 232 GCC Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 233 GCC Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 234 GCC Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 235 GCC Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 236 GCC Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 237 GCC Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 238 GCC Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 239 GCC Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 240 GCC Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 241 Africa Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 242 Africa Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 243 Africa Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 244 Africa Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 245 Africa Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 246 Africa Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 247 Africa Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 248 Africa Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 249 Africa Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 250 Africa Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)
TABLE 251 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Disease, 2020-2030, USD (Million)
TABLE 252 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Upper respiratory tract infection, 2020-2030, USD (Million)
TABLE 253 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Lower respiratory tract infection, 2020-2030, USD (Million)
TABLE 254 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Drug, 2020-2030, USD (Million)
TABLE 255 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Antibiotics, 2020-2030, USD (Million)
TABLE 256 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Antibacterial, 2020-2030, USD (Million)
TABLE 257 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Antiviral, 2020-2030, USD (Million)
TABLE 258 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Non-steroidal anti-inflammatory drug (NSAIDS), 2020-2030, USD (Million)
TABLE 259 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Cough suppresant, 2020-2030, USD (Million)
TABLE 260 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market By Nasal decongestant, 2020-2030, USD (Million)

List of Figures

FIG. 1 Global Respiratory Tract Infection Treatment Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Respiratory Tract Infection Treatment Market: Quality Assurance
FIG. 5 Global Respiratory Tract Infection Treatment Market, By Disease, 2021
FIG. 6 Global Respiratory Tract Infection Treatment Market, By Drug, 2021
FIG. 7 Global Respiratory Tract Infection Treatment Market, By Geography, 2021
FIG. 8 Market Geographical Opportunity Matrix - Global Respiratory Tract Infection Treatment Market, 2021
FIG. 9 Market Positioning of Key Respiratory Tract Infection Treatment Market Players, 2021
FIG. 10 Global Respiratory Tract Infection Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
FIG. 11 Global Respiratory Tract Infection Treatment Market, By Disease, 2021 Vs 2030, %
FIG. 12 Global Respiratory Tract Infection Treatment Market, By Drug, 2021 Vs 2030, %
FIG. 13 U.S. Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 14 Canada Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 15 Rest of North America Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 16 UK Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 17 Germany Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 18 Spain Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 19 Italy Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 20 France Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 21 Rest of Europe Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 22 China Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 23 Japan Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 24 India Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 25 Australia Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 26 South Korea Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 27 Rest of Asia Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 28 Brazil Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 29 Mexico Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 30 Rest of Latin America Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 31 GCC Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 32 Africa Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030
FIG. 33 Rest of Middle East and Africa Respiratory Tract Infection Treatment Market (US$ Million), 2020 - 2030

Product Code: 137543-08-22

This report on global respiratory tract infection treatment market studies various diseases and drug class. Rising prevalence of respiratory illness as per World Health Organization in 2015 three million deaths were recorded due to COPD, constantly changing climate, rising air pollution and increasing inclination to maintain personal hygiene are the drivers for the respiratory tract infection treatment market. The limiting factors related to this market are the rising incidence of antibiotic resistance and adverse events relating to the consumption of NSAIDs will hinder the growth of respiratory infection treatment market. Technological advancement in pharmacokinetics and drug screening for adverse events will result into deep market penetration. The increasing consumption of cheap generic medicines will hinder the branded drugs market. The drugs in the pipeline are Relenza (GSK), MK7264 (Merck & Co.), Presatovir (Gilead) and AZD7594, PT010 (AstraZeneca) etc.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global respiratory tract infection treatment market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global respiratory tract infection treatment market. The key players profiled in this report are Abbott Laboratories, Abbvie Inc, AstraZeneca, Boehringer Ingelheim GmbH, Cipla Pharmaceutical Company, GlaxoSmithKline plc, Pfizer Inc., Novartis AG and others.

Respiratory Tract Infection Treatment Based on disease

Respiratory tract infection is one of the most common reason for the patients to visit the clinic or hospital. In base year 2021, Upper tract respiratory infection holds the largest market in the disease segment due to factors like, constant change in climate and rising air pollution, rising number of patients suffering with common cold as many types of viruses cause common cold, gross negligence when it comes to personal hygiene like sneezing, coughing (uncovered face) and touching inanimate objects with contaminated hands. Lower respiratory tract infection will be the fastest growing market in the disease segment throughout the forecast period 2022-2030 chiefly due to factors such as rising number of air particulate matters which are exhumed by industrial chimneys and automobiles cause lower respiratory tract irritation and infection, on the basis of transmission it might be hospital acquired, ventilator acquired and community acquired. Technological advancement in the exact diagnosis of the causative agent in order to determine the treatment regimen for diseases like asthma, COPD and respiratory syncytial virus will be a positive factor for the fast growth of respiratory tract infection treatment market during the forecast period.

Respiratory Tract Infection Treatment Based on drug class

Respiratory tract infection treatment are having huge application due to factors such as rising prevalence of respiratory tract infections, constant change in climate, rising air pollution and increasing cases of antibiotics resistance. In base year 2021, Non-steroidal anti-inflammatory drugs (NSAIDS) holds the largest market in the drug treatment segment chiefly due to factors such as low cost, easy availability as OTC products, immediate symptomatic relief and technological advancement in the drug formulation e.g. micronized NSAIDs have desirable pharmacodynamics activity and early excretion rate to overcome NSAIDs adverse events. Antibiotics will be the fastest growing market in the drug treatment segment throughout the forecast period of 2022-2030 mainly due to factors such as its diverse application in various respiratory tract infections, improved pharmacokinetics to specifically target the respiratory tract infection for e.g. nebulized Aztreonam formulation is more effective than Aztreonam tablets, and technological advancement in the antibiotics resulting into next generation broad spectrum antibiotics e.g. methicillin formulated with branched polyethylenimine polymer to counteract antibiotic resistant cells. Overall, the global respiratory tract infection treatment market is highly competitive with presence of multiple players like Abbott Laboratories, AstraZeneca, Boehringer Ingelheim GmbH, Pfizer, Inc., GlaxoSmithKline plc specializing in respective fields. Consolidation activities are being increasingly witnessed on the competitive front with a view to increase the market growth for respiratory tract infection treatment.

North America was observed as the largest market for respiratory tract infection treatment in the base year 2021. According to Centers for Disease Control and Prevention (CDC) American adults have 2 to 3 colds per year with underlying symptoms such as runny nose, sore throat, coughing, sneezing, headaches and body aches. The growth is attributed mainly due to large population suffering from respiratory complications and inclination to maintain personal hygiene along with favorable reimbursement scenario. Europe is expected to be the second largest market due to cool and damp weather favoring respiratory disease and regulatory approval for respiratory tract infection treatment products. Growth of Asia Pacific for respiratory tract infection treatment market is attributed by factors like rising prevalence of respiratory illness among huge population base, competitive market due to manufactures involved in respiratory tract infection treatment products, and impact of monsoon weather in the South Asian countries. However, factors such as developing health infrastructure, increasing disease awareness and increasing demand for respiratory tract infection treatment products are going to fuel the growth of respiratory tract infection treatment market in Latin America and Middle East and Africa region in the near future.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Respiratory Tract Infection Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Respiratory Tract Infection Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Disease

Upper respiratory tract infection
- Common cold
- Sinusitis
- Epiglottitis
- Laryngitis

Lower respiratory tract infection
- Flu
- Bronchitis
- Pnuemonia
- Chronic obstructive pulmonary disease (COPD)

Asthma
Respiratory syncytial virus

Drug

Antibiotics
- Antibacterial
  - Cephalosporin (ceftriaxone, cefotaxime)
  - Penicillin antibiotic (amoxicillin, ampicillin)
  - B lactactamase inhibitors (sulbactum,clavulanic acid)
- Antiviral
  - Ribavarin
  - Palivizumab
  - Ganciclovir
  - Vidarabine

Non-steroidal anti-inflammatory drug (NSAIDS)
- Paracetamol
- Ibuprofen
- Naproxen
- Aspirin

Cough suppresant
- Dextromethorphan
- Pholcodine
- Benzonatate
- Diphenhydramine

Nasal decongestant
- Phenylephrine
- Oxymetazoline
- Pseudoephedrine

Others

Region Segment (2020-2030; US$ Million)

North America
- U.S.
- Canada
- Rest of North America

UK and European Union
- UK
- Germany
- Spain
- Italy
- France
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific

Latin America
- Brazil
- Mexico
- Rest of Latin America

Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation
Post Covid-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Respiratory Tract Infection Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Respiratory Tract Infection Treatment market?

Which is the largest regional market for Respiratory Tract Infection Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Respiratory Tract Infection Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Respiratory Tract Infection Treatment market worldwide?

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Respiratory Tract Infection Treatment Market
2.2. Global Respiratory Tract Infection Treatment Market, By Disease, 2021 (US$ Million)
2.3. Global Respiratory Tract Infection Treatment Market, By Drug, 2021 (US$ Million)
2.4. Global Respiratory Tract Infection Treatment Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021

3. Respiratory Tract Infection Treatment Market: Competitive Analysis

3.1. Market Positioning of Key Respiratory Tract Infection Treatment Market Vendors
3.2. Strategies Adopted by Respiratory Tract Infection Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Respiratory Tract Infection Treatment Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Respiratory Tract Infection Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
- 5.3.1. Upper respiratory tract infection
  - 5.3.1.1. Common cold
  - 5.3.1.2. Sinusitis
  - 5.3.1.3. Epiglottitis
  - 5.3.1.4. Laryngitis
- 5.3.2. Lower respiratory tract infection
  - 5.3.2.1. Flu
  - 5.3.2.2. Bronchitis
  - 5.3.2.3. Pnuemonia
  - 5.3.2.4. Chronic obstructive pulmonary disease (COPD)
- 5.3.3. Asthma
- 5.3.4. Respiratory syncytial virus

6. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
- 6.3.1. Antibiotics
  - 6.3.1.1. Antibacterial
    - 6.3.1.1.1. Cephalosporin (ceftriaxone, cefotaxime)
    - 6.3.1.1.2. Penicillin antibiotic (amoxicillin, ampicillin)
    - 6.3.1.1.3. B lactactamase inhibitors (sulbactum,clavulanic acid)
  - 6.3.1.2. Antiviral
    - 6.3.1.2.1. Ribavarin
    - 6.3.1.2.2. Palivizumab
    - 6.3.1.2.3. Ganciclovir
    - 6.3.1.2.4. Vidarabine
- 6.3.2. Non-steroidal anti-inflammatory drug (NSAIDS)
  - 6.3.2.1. Paracetamol
  - 6.3.2.2. Ibuprofen
  - 6.3.2.3. Naproxen
  - 6.3.2.4. Aspirin
- 6.3.3. Cough suppresant
  - 6.3.3.1. Dextromethorphan
  - 6.3.3.2. Pholcodine
  - 6.3.3.3. Benzonatate
  - 6.3.3.4. Diphenhydramine
- 6.3.4. Nasal decongestant
  - 6.3.4.1. Phenylephrine
  - 6.3.4.2. Oxymetazoline
  - 6.3.4.3. Pseudoephedrine
- 6.3.5. Others

7. North America Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

7.1. Market Overview
7.2. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
7.3. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
7.4.Respiratory Tract Infection Treatment Market: By Region, 2020-2030, USD (Million)
- 7.4.1.North America
  - 7.4.1.1. U.S.
    - 7.4.1.1.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 7.4.1.1.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 7.4.1.2. Canada
    - 7.4.1.2.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 7.4.1.2.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 7.4.1.3. Rest of North America
    - 7.4.1.3.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 7.4.1.3.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

8. UK and European Union Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

8.1. Market Overview
8.2. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
8.3. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
8.4.Respiratory Tract Infection Treatment Market: By Region, 2020-2030, USD (Million)
- 8.4.1.UK and European Union
  - 8.4.1.1. UK
    - 8.4.1.1.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 8.4.1.1.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 8.4.1.2. Germany
    - 8.4.1.2.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 8.4.1.2.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 8.4.1.3. Spain
    - 8.4.1.3.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 8.4.1.3.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 8.4.1.4. Italy
    - 8.4.1.4.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 8.4.1.4.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 8.4.1.5. France
    - 8.4.1.5.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 8.4.1.5.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 8.4.1.6. Rest of Europe
    - 8.4.1.6.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 8.4.1.6.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

9. Asia Pacific Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

9.1. Market Overview
9.2. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
9.3. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
9.4.Respiratory Tract Infection Treatment Market: By Region, 2020-2030, USD (Million)
- 9.4.1.Asia Pacific
  - 9.4.1.1. China
    - 9.4.1.1.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 9.4.1.1.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 9.4.1.2. Japan
    - 9.4.1.2.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 9.4.1.2.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 9.4.1.3. India
    - 9.4.1.3.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 9.4.1.3.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 9.4.1.4. Australia
    - 9.4.1.4.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 9.4.1.4.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 9.4.1.5. South Korea
    - 9.4.1.5.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 9.4.1.5.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 9.4.1.6. Rest of Asia Pacific
    - 9.4.1.6.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 9.4.1.6.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

10. Latin America Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

10.1. Market Overview
10.2. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
10.3. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
10.4.Respiratory Tract Infection Treatment Market: By Region, 2020-2030, USD (Million)
- 10.4.1.Latin America
  - 10.4.1.1. Brazil
    - 10.4.1.1.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 10.4.1.1.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 10.4.1.2. Mexico
    - 10.4.1.2.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 10.4.1.2.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 10.4.1.3. Rest of Latin America
    - 10.4.1.3.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 10.4.1.3.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

11. Middle East and Africa Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

11.1. Market Overview
11.2. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
11.3. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
11.4.Respiratory Tract Infection Treatment Market: By Region, 2020-2030, USD (Million)
- 11.4.1.Middle East and Africa
  - 11.4.1.1. GCC
    - 11.4.1.1.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 11.4.1.1.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 11.4.1.2. Africa
    - 11.4.1.2.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 11.4.1.2.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)
  - 11.4.1.3. Rest of Middle East and Africa
    - 11.4.1.3.1. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)
    - 11.4.1.3.1. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

12. Company Profile

12.1. Abbott Laboratories
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Portfolio
- 12.1.4. Strategic Initiatives
12.2. AstraZeneca
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Portfolio
- 12.2.4. Strategic Initiatives
12.3. Abbvie Inc.
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Portfolio
- 12.3.4. Strategic Initiatives
12.4. Boehringer Ingelheim GmbH
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Portfolio
- 12.4.4. Strategic Initiatives
12.5. Cipla Pharmaceutical Company
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Portfolio
- 12.5.4. Strategic Initiatives
12.6. GlaxoSmithkline plc
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Portfolio
- 12.6.4. Strategic Initiatives
12.7. Pfizer Inc.
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Portfolio
- 12.7.4. Strategic Initiatives
12.8. Merck & Co.
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Portfolio
- 12.8.4. Strategic Initiatives
12.9. Novartis AG
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Portfolio
- 12.9.4. Strategic Initiatives
12.10. F.Hoffman La Roche Ltd
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Portfolio
- 12.10.4. Strategic Initiatives
12.11. Sanofi
- 12.11.1. Company Overview
- 12.11.2. Financial Performance
- 12.11.3. Product Portfolio
- 12.11.4. Strategic Initiatives
12.12. Teva Pharmaceutical Industries Ltd.
- 12.12.1. Company Overview
- 12.12.2. Financial Performance
- 12.12.3. Product Portfolio
- 12.12.4. Strategic Initiatives
12.13. Theravence Biopharma
- 12.13.1. Company Overview
- 12.13.2. Financial Performance
- 12.13.3. Product Portfolio
- 12.13.4. Strategic Initiatives
12.14. Vertex Pharmaceuticals Inc.
- 12.14.1. Company Overview
- 12.14.2. Financial Performance
- 12.14.3. Product Portfolio
- 12.14.4. Strategic Initiatives
12.15. Others
- 12.15.1. Company Overview
- 12.15.2. Financial Performance
- 12.15.3. Product Portfolio
- 12.15.4. Strategic Initiatives

呼吸器感染症治療薬の世界市場 (2022～2030年)：成長・将来の展望・競合分析

Respiratory Tract Infection Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 呼吸器感染症治療薬市場：競合分析

第4章 呼吸器感染症治療薬市場：マクロ分析・市場力学

第5章 呼吸器感染症治療薬市場：疾患別

第6章 呼吸器感染症治療薬市場：薬剤別

第7章 北米の呼吸器感染症治療薬市場

第8章 英国およびEUの呼吸器感染症治療薬市場

第9章 アジア太平洋の呼吸器感染症治療薬市場

第10章 ラテンアメリカの呼吸器感染症治療薬市場

第11章 中東およびアフリカの呼吸器感染症治療薬市場

第12章 企業プロファイル

List of Tables

List of Figures

Respiratory Tract Infection Treatment Based on disease

Respiratory Tract Infection Treatment Based on drug class

Historical & Forecast Period

Research Methodology

Geographical revenues generate by countries considered in the report:

Market Segmentation

Disease

Drug

Region Segment (2020-2030; US$ Million)

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Key questions answered in this report:

Table of Contents

1. Preface

2. Executive Summary

3. Respiratory Tract Infection Treatment Market: Competitive Analysis

4. Respiratory Tract Infection Treatment Market: Macro Analysis & Market Dynamics

5. Respiratory Tract Infection Treatment Market: By Disease, 2020-2030, USD (Million)

6. Respiratory Tract Infection Treatment Market: By Drug, 2020-2030, USD (Million)

7. North America Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

8. UK and European Union Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

9. Asia Pacific Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

10. Latin America Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

11. Middle East and Africa Respiratory Tract Infection Treatment Market, 2020-2030, USD (Million)

12. Company Profile

第1章序文

第2章エグゼクティブサマリー

第3章呼吸器感染症治療薬市場：競合分析

第4章呼吸器感染症治療薬市場：マクロ分析・市場力学

第5章呼吸器感染症治療薬市場：疾患別

第6章呼吸器感染症治療薬市場：薬剤別

第7章北米の呼吸器感染症治療薬市場

第8章英国およびEUの呼吸器感染症治療薬市場

第9章アジア太平洋の呼吸器感染症治療薬市場

第10章ラテンアメリカの呼吸器感染症治療薬市場

第11章中東およびアフリカの呼吸器感染症治療薬市場

第12章企業プロファイル